---
title: "AmoyDx shareholder Xiamen Yixiang plans to reduce its holdings by no more than 3%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238946458.md"
description: "According to the Zhitong Finance APP, AmoyDx announced that the company recently received a \"Reduction Plan Notification Letter\" issued by its shareholder Xiamen Yixiang Investment Partnership (Limited Partnership) (\"Xiamen Yixiang\"), intending to reduce its holdings by no more than 11.7918 million shares, which is no more than 3.00% of the company's total share capital"
datetime: "2025-05-06T14:43:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238946458.md)
  - [en](https://longbridge.com/en/news/238946458.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238946458.md)
generator: "portal-rs"
---

# AmoyDx shareholder Xiamen Yixiang plans to reduce its holdings by no more than 3%

According to the announcement from Zhitong Finance APP, AmoyDx (300685.SZ) recently received a "Reduction Plan Notification Letter" issued by its shareholder Xiamen Yixiang Investment Partnership (Limited Partnership) ("Xiamen Yixiang"), intending to reduce its holdings by no more than 11.7918 million shares, which is no more than 3.00% of the company's total share capital

### Related Stocks

- [300685.CN](https://longbridge.com/en/quote/300685.CN.md)

## Related News & Research

- [Can Xiaomi Take On Porsche On Its Home Turf? It’s About To Try](https://longbridge.com/en/news/297946941.md)
- [LithiumBank shares trade on Germany’s Tradegate Exchange under symbol HT9](https://longbridge.com/en/news/297910536.md)
- [Costa Rica President: U.S. forces would help national security](https://longbridge.com/en/news/298065948.md)
- [Fed ends enforcement action against United Texas Bank](https://longbridge.com/en/news/298057655.md)
- [Biohit says scientific review backs serum biomarker triage to target endoscopy for gastric cancer risk](https://longbridge.com/en/news/297887371.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**